Patents by Inventor Craig Robson

Craig Robson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10947328
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: March 16, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20200255552
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 13, 2020
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 10662264
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: May 26, 2020
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20180194877
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 12, 2018
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 9944725
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: April 17, 2018
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20170044276
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 9505884
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: November 29, 2016
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20160083519
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Application
    Filed: December 9, 2015
    Publication date: March 24, 2016
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 9238717
    Abstract: A non-leaching mediator may include a polymer comprising the general formula (VIII): and salts thereof, where R? is an organic group, m is 0 or 1, n is about 9, and x and y independently are an integer from 1 to 10,000.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: January 19, 2016
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20140235797
    Abstract: A non-leaching mediator may include a polymer comprising the general formula (VIII): and salts thereof, where R? is an organic group, m is 0 or 1, n is about 9, and x and y independently are an integer from 1 to 10,000.
    Type: Application
    Filed: April 23, 2014
    Publication date: August 21, 2014
    Applicant: Bayer HealthCare LLC
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 8742063
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: June 3, 2014
    Assignee: Bayer HealthCare LLC
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Publication number: 20110294959
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Application
    Filed: May 26, 2011
    Publication date: December 1, 2011
    Applicant: BAYER HEALTHCARE LLC
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 7017042
    Abstract: Methods and apparatus' for performing IPSec processing on an IP packet being transmitted onto a network and being received from a network are described. The methods and apparatus' further described perform IPSec processing inline which results in a reduced number of transfers over the system bus, reduced utilization of system memory, and a reduced utilization of the system CPU. An IP packet which requires IPSec processing enters an acceleration device. In one embodiment, the acceleration device is coupled to a security policy database (SPD) and security association database (SAD). IPSec processing is performed at the acceleration device without sending the IP Packet to system memory for processing.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: March 21, 2006
    Inventors: Syrus Ziai, Greg Grohoski, Craig Robson, Tim Barry, Paul Hartke
  • Patent number: 6983382
    Abstract: Methods and apparatus' for performing SSL processing on an IP packet being transmitted onto a network and being received from a network are described. The methods and apparatus' further described performing SSL processing inline which results in a reduced number of transfers over the system bus, reduced utilization of system memory, and a reduced utilization of the system CPU. An IP packet that requires SSL processing enters an acceleration device. SSL processing is performed at the acceleration device without first sending the IP packet to system memory for processing.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: January 3, 2006
    Inventors: Paul Hartke, Craig Robson, Syrus Ziai, Greg Grohoski
  • Patent number: 6976205
    Abstract: A method is described that involves performing a checksum calculation on a section of data within an inbound packet before the section of data is first stored into a system memory. Another method is described that involves moving a section of data within an outbound packet from a system memory to an offload memory. Then, removing the section of data from the offload memory; and performing a checksum calculation on the section of data. An apparatus is described that includes a central processing unit that is communicatively coupled with a network processing offload unit, wherein the network processing offload unit calculates a checksum upon a section of data located within an inbound packet, and calculates a checksum upon a section of data within an outbound packet.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: December 13, 2005
    Assignee: Syrus Ziai
    Inventors: Syrus Ziai, Paul Jordan, Craig Robson, Ryan Donohue, Fong Pong
  • Patent number: 6330099
    Abstract: An apron and a skirt of a spatial light modulator are each coupled to a substrate by reverse-bias diodes. The spatial light modulator includes liquid crystal material between an array of electrodes and a ground electrode. The apron surrounds the array, and the segmented skirt surrounds the apron. The array, apron, and skirt are formed over the substrate. The reverse-bias diodes provide suitable electrical isolation during normal operation, but dissipate excessive charge that might accumulate during plasma etching as the modulator is being manufactured and that might otherwise induce damage due to electrostatic discharge.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: December 11, 2001
    Assignee: Agilent Technologies, Inc.
    Inventors: Douglas Sojourner, Craig Robson, Harold Dean Lewis